MedPath
HSA Approval

VABOREM POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/1G

SIN17224P

VABOREM POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/1G

VABOREM POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/1G

April 25, 2025

A. MENARINI SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantA. MENARINI SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS DRIP

Medical Information

J01DH52

Manufacturer Information

A. MENARINI SINGAPORE PTE. LTD.

ACS DOBFAR S.P.A.

Active Ingredients

MEROPENEM TRIHYDRATE eqv MEROPENEM

1 g

Meropenem

VABORBACTAM

1 g

Vaborbactam

Documents

Package Inserts

Vaborem PI.pdf

Approved: April 25, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VABOREM POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/1G - HSA Approval | MedPath